Study of Losartan in the Treatment of NAFLD in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
NAFLD
Interventions
DRUG

Losartan

Oral tablet to be taken once daily at 0.4mg/kg/day (max 25mg) for one week and then increased to 0.8mg/kg/day (max 50mg) for 7 additional weeks.

Trial Locations (1)

30322

Emory University / Children's Healthcare of Atlanta, Atlanta

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Children's Healthcare of Atlanta

OTHER

lead

Miriam Vos, MD

OTHER